Browse drugs

… Internal trust guideline.2024.Patel J, Lucas C, Ryan J, et al. Vancomycin therapeutic drug monitoring in paediatrics. Paediatr Child Heal…

…comitantly taking the nephrotoxic drug, cytarabine and thus the vancomycin was discontinued.Conclusion This study highlights that continuo…

…he therapeutic range (10–20 µg/mL) (p <0.001). Of the total 238 vancomycin trough concentrations taken from patients, 77 (32.4%) were meas…

…02 Optimising vancomycin use: a retrospective audit of neonatal vancomycin infusion therapy. BMJ Paediatrics Open. 2025;9:. https://doi.or…

…ycin vials to capsules for second-line treatment; the rest used fidaxomicin. At the end, 100% of the CDI cases resolved.Conclusion and Rele…

…phylaxis (7%), fever of unknown origin (6%), and pneumonia (6%).Vancomycin was switched to linezolid in 40 treatments (58%), daptomycin in…

…round and Importance There is a growing interest in intravenous vancomycin therapy supported by therapeutic drug monitoring (TDM). In addi…

…lusions The CG formula provides the most accurate prediction of vancomycin Cmin. In patients with eGFR <60 mL/min and aged 46–75 years, MD…

…obtained from 29 patients (72% male, mean age 56,2±20,1 years). Tobramycin (300 mg/12 h) showed systemic absorption (Cp_tobra > 0,1µg/mL) …

…eity of renal function among infectious patients make adjusting vancomycin dosages to effectively treat infections difficult. Currently, t…

…al challenge with high mortality, despite guideline-recommended vancomycin therapy. Although a ratio of the area under the curve to the mi…

…y for 7 days (mimicking patient conditions).Conclusions The new vancomycin eye drop formulation remains stable even in cases of temperatur…